openPR Logo
Press release

Sales Revenue of Orally Disintegrating Tablets Market to Grow at 11.5% CAGR by 2025

09-19-2017 12:54 PM CET | Health & Medicine

Press release from: Persistence Market Research Pvt.Ltd

Sales Revenue of Orally Disintegrating Tablets Market to Grow

The report profiles some of the leading companies operating in the global orally disintegrating tablets market such as Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Valeant, GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Bayer AG, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Zydus Cadila, NEOS Therapeutics, Inc., Glenmark, and Unichem Laboratories.

In a new report titled ‘Orally Disintegrating Tablets Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research studies the performance of the global orally disintegrating tablets market over an eight year period from 2017 to 2025 and presents a detailed forecast of the market both for the historical period 2012 – 2016 as well as for the forecasted period of 2017 – 2025.

According to Persistence Market Research, the global orally disintegrating tablets market is predicted to grow at a significant pace during the assessment period owing to a rising preference for orally disintegrating tablets among patients and physicians alike; coupled with the fact that orally disintegrating tablets minimize the scope for dosage errors and are ideal for administering to patients of all age groups.

These factors are likely to boost revenue growth of the global orally disintegrating tablets market, which is anticipated to rise from an estimated US$ 11.4 Bn in 2017 to about US$ 27 Bn by the end of 2025, witnessing a CAGR of 11.5% in terms of value during the forecast period.

In this report, Persistence Market Research segments the global orally disintegrating tablets market on the basis of drug class, disease indication, distribution channel, and region.

View and Download TOC of Orally Disintegrating Tablets Market Research Report@ https://www.persistencemarketresearch.com/market-research/orally-disintegrating-tablet-market/toc

In terms of drug class, the global orally disintegrating tablets market is further segmented into Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitor, and Others. Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight year period.

Under this category, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases, Allergy, and Others. CNS Diseases segment will hold maximum revenue share in the global market, and Persistence Market Research forecasts indicate a 55% market share for this segment by the end of the forecast period in 2025. The CNS Diseases segment is forecasted to reach a market valuation of about US$ 15 Bn by 2025 end, registering a CAGR of 13.2%. This is slated to be the most dominant segment by disease indication in the global orally disintegrating tablets market.

Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/14572

Of the various distribution channels of orally disintegrating tablets viz., Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies, Hospital Pharmacies will be the undisputed leader in terms of market share throughout the forecast period, anticipated to account for nearly 49% value share by the end of 2025. A market valuation of about US$ 13 Bn by the end of 2025 with a 13.2% CAGR is likely to be in store for this segment.

Persistence Market Research tracks the performance of the global orally disintegrating tablets market across the key geographies of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is slated to dominate the global market throughout the forecast period, with an estimated 35% market share and a market value of about US$ 9.7 Bn by the end of 2025. This is reflective of a CAGR of 11.7% during the forecast period.

Buy Full Orally Disintegrating Tablets Market Report@ https://www.persistencemarketresearch.com/checkout/14572

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sales Revenue of Orally Disintegrating Tablets Market to Grow at 11.5% CAGR by 2025 here

News-ID: 726152 • Views:

More Releases from Persistence Market Research Pvt.Ltd

Global Food Fiber Market is forecast to expand at a CAGR of 5.7% from 2017 to 2025
Global Food Fiber Market is forecast to expand at a CAGR of 5.7% from 2017 to 20 …
Some of the prominent players operating in the global food fiber market are J. RETTENMAIER & SÖHNE GmbH, Co KG, Kerry Group, Grain Processing Corporation, Nexira, SunOpta, Inc., Ingredion Roquette Frères S.A., Archer-Daniels-Midland Company, Tate & Lyle plc, and Cargill, Inc., notes Persistence Market Research (PMR). Several of these players are investing on advanced fiber fortification technologies for developing innovative formulations that have a variety of functional health benefits, in
In Vitro Protein Expression Market Accounting for US$ 250 Mn in 2025
In Vitro Protein Expression Market Accounting for US$ 250 Mn in 2025
Persistence Market Research has come up with an analytical research publication titled “In Vitro Protein Expression Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” The comprehensive in vitro protein expression market research report focuses on various trends, developments, opportunities, restraints, drivers and challenges impacting the growth of the global in vitro protein expression market. These factors vary in magnitude in different regions for which a detailed analysis is covered in
Tert-Amyl Methyl Ether Market Estimated to Experience a Hike in Growth by 2025
Tert-Amyl Methyl Ether Market Estimated to Experience a Hike in Growth by 2025
Introduction Ether compounds such as MTBE, ETBE, TAEE and TAME are used in fuel especially in gasoline in order to improve the combustion properties of fuels. Among these compounds, Tert-Amyl Methyl Ether used as oxygenated additive for the gasoline. Tert-Amyl Methyl Ether, formula (CH3)3 CH2COCH3, is an organic compound, used in fuel to improve its octane number. TAME is generally produced through the catalytic reaction between methanol (MeOH) and the 2-methyl-2-butene
Radar Simulator Market Significant Profits Estimated to be Generated by 2025
Radar Simulator Market Significant Profits Estimated to be Generated by 2025
Radar simulator market is on upward scale, owing to increase in adaptation of modern technologies for the training purpose in commercial and military aircrafts & ships. Radar simulator is either software solution or combination of both software and hardware. Radar simulators emulate various radars and initiate their working to provide users with an artificial and apt environment for radar training and functional/system testing. The software solutions can be installed in

All 5 Releases


More Releases for Disintegrating

Computed Tomography to Drive The Orally Disintegrating Tablet Market
The Orally Disintegrating Tablet Market is expected to climb up the ladder of persistence in the next decade. With various healthcare apps on the anvil, there are also mindfulness apps being tabled. They fall in the category of "Wellness apps". With the world wishing for the post-Covid era to function smoothly, these wellness apps are expected to take the healthcare vertical by storm further. Improvements in drug delivery mechanism offering quicker
Global Industry Analysis of Disintegrating Agents
Disintegrating agents are chemical agents consisting of a mixture of substances or a single substance that are added to tablets and other encapsulated formulations to facilitate disintegration of the capsule or tablet into smaller remains for better discharge of the drug in the body. This process helps provide better results of the drug on the body. Disintegrating agents primarily find application in the pharmaceutical industry. These agents are used
Orally Disintegrating Tablets Market Progresses for Huge Profits During - 2027
A research report on "Orally Disintegrating Tablets Market2019 Industry Research Report. This is a key document as far as the clients and industries are concerned to not only understand the competitive market status that exists currently but also what future holds for it in the upcoming period, i.e., between 2018 and 2027. The report has categorized in terms of region, type, key industries, and application. Global Orally Disintegrating Tablets Market revenue
Global Orally Disintegrating Tablet Excipient Market Growth 2019-2024
Market Research Report Store offers a latest published report on Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Orally Disintegrating Tablet Excipient market will register a 3.7% CAGR in terms of revenue, the global market size will reach US$ 17110 million by 2024, from US$ 14820
Disintegrating Agents Market Outlook and Growth Report | 2025
Disintegrating agents are chemical agents consisting of a mixture of substances or a single substance that are added to tablets and other encapsulated formulations to facilitate disintegration of the capsule or tablet into smaller remains for better discharge of the drug in the body. This process helps provide better results of the drug on the body. Disintegrating agents primarily find application in the pharmaceutical industry. These agents are used in
Global Orally Disintegrating Tablet Market Growth Analysis
Qyresearchreports include new market research report Global Orally Disintegrating Tablet Sales Market Report 2018 to its huge collection of research reports. The global Orally Disintegrating Tablet market has been explained in details in the report. It offers various crucial statistics pertaining to the revenue, products and applications, and geography of the market. Apart from that, the report also collates information on the different macro-fundamentals and other factors promoting or hindering the